Globe Life Inc Dossier - Source-backed chat

Globe Life Inc

GLNYSE

SectorFinancials

IndustryLife & Health Insurance

Beta (adjusted)0.65

Intrinsic Value $125.36median of 2 methodsbased on filings through 30 Jun 2026

Market Price $165.83Price as of 1 Oct 2026

OvervaluedIntrinsic value is 24% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $12.7B

Enterprise Value $15.4B

Shares Outstanding 78.2M diluted

Next Earnings Date26 Oct 2026

Next ex-dividend5 Oct 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Globe Life entered the second half of 2026 with favorable operating momentum: second-quarter net operating income per diluted share increased 10%, total premium revenue grew 7%, management raised full-year operating-earnings guidance, and the board subsequently authorized up to $2.5 billion of future share repurchases. The neutral recommendation reflects offsetting distribution and execution concerns, including a 3% decline in total life net sales, a 15% decline in Direct to Consumer life net sales, and a 7% contraction in American Income's average producing-agent count.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets11 analysts · as of 18 Aug 2026

Low · most bearish analyst$166.00

Mean target$193.91

High · most bullish analyst$225.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$166.0020%

American Income's agent contraction persists or spreads to sales and premiums, Direct to Consumer life sales remain weak, portfolio credit quality deteriorates, or litigation and regulatory developments impair earnings or capital deployment despite the current guidance.

Base CaseCentral scenario

$193.9155%

Matches the consensus mean

Operating earnings remain within management's $15.55-$15.95 range. Premium and underwriting growth continue, but weak American Income agent trends and softer life net sales limit the quality of the expansion.

Bull CaseUpside scenario

$225.0025%

Operating earnings reach the upper portion of management's $15.55-$15.95 range, American Income recruiting stabilizes, life sales recover, health-premium growth remains strong, and disciplined execution of the new $2.5 billion repurchase authorization compounds per-share growth.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Second-quarter net operating income per diluted share increased 10%, and management reported double-digit growth in eight of the preceding nine quarters while raising full-year 2026 guidance.
Total premium revenue grew 7%, supported by 16% health-premium growth and 29% growth in United American health premiums.
The board authorized up to $2.5 billion of future common-stock repurchases, replacing prior authorizations and signaling continued emphasis on excess-capital returns.

Key Investment Risks

Total life net sales declined 3%, including a 15% decline in Direct to Consumer and a 2% decline at American Income.
American Income's average producing-agent count declined 7% year over year, creating a distribution-capacity risk for future sales and premium growth.
Litigation, regulatory actions, credit deterioration, ratings changes, and adverse interest-rate movements remain identified sources of earnings, liquidity, and capital-allocation risk.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.